Delivery Order SPE2DB24D1201-SPE2DB25FJDWX
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $9,781.40 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on June 24, 2025, for the supply of Forteo 560 MCG/2.24 ML pen injections. The award is a child delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This competitively awarded, non-set-aside contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,658.09 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562987588 FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 5, 2023. No set-aside designation was applied to this award made under an existing indefinite delivery contract...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,787,334 units of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. The delivery order, valued at $10,977.38, has a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and has received numerous...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $3,674.91 firm fixed price delivery order by the Defense Logistics Agency to supply 4562155232 FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. Performance will take place in Conshohocken, Pennsylvania over one day in September 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, responsible for worldwide logistical support. This delivery...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,640.39 firm fixed-price contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The award has an ultimate completion date of April 26, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on September 18, 2025, valued at $20,560.37 for the supply of Forteo (560 mcg/2.24 mL pen injections) to support the Defense Logistics Agency's Medical Supply Chain. The contract is firm fixed price with no set-aside designation, and performance is scheduled for completion by September 19, 2025, with the place of performance located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical Center. This $10,632.36 order is for the delivery of 4562941171 units of Forteo 600 mcg/2.4 ml pen injections to the specified place of performance in Conshohocken, Pennsylvania by November 30, 2023. As a prime contractor supporting pharmaceutical distribution to DLA...
- The Defense Logistics Agency awarded a $16,156.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on May 30, 2025, with an ultimate completion date of June 2, 2025. This is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,833.32, is a Firm Fixed Price Delivery Order for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,038.12 firm fixed price delivery order is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through December 31, 2025, which serves...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDWXDelivery Order
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,652.67 by the Defense Logistics Agency (DLA) for the supply of FORTEO 560 MCG/2.24 ML pen injections. This competitive, non-set-aside award represents a firm fixed price contract with an ultimate completion date of August 13, 2025, and is classified as a child contract under a larger vehicle. The product will be performed at AmerisourceBergen's Conshohocken facility, reflecting the company's role as a critical pharmaceutical supplier to federal military and healthcare systems. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's extensive federal portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/12/25 |